GLP Watchdog

Gala vs Ivy Rx

Neither Gala nor Ivy Rx has an FDA warning letter on record. On compounded tirzepatide injection, Gala costs $1,416 less a year at standing rates: $179 a month against $297 a month at Ivy Rx. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Ivy Rx

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

Ivy Rx logo

Ivy Rx

7.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$197/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Gala
Visit Ivy Rx

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Ivy Rx pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Ivy Rx 7.3). How we are paid

What the record shows

  1. 01

    Neither Gala nor Ivy Rx has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded tirzepatide injection, Gala costs $1,416 less a year at standing rates: $179 a month against $297 a month at Ivy Rx. It is one of two products the two sell at comparable terms.

  4. 04

    Only Gala lists a price for brand-name semaglutide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Ivy Rx

Compounded semaglutide injection

$179/moLower

$2,148 a year

$197/mo

$2,364 a year

Compounded tirzepatide injection

$179/moLower

$2,148 a year

$297/mo

$3,564 a year

Brand-name semaglutide pen

$1,299/mo

$15,588 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
None
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
All transactions are final; no returns
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Gala: October 17, 2026. Ivy Rx: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • $216 a year less on compounded semaglutide injection
  • $1,416 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen, which Ivy Rx does not price
  • Names no compounding pharmacy
Visit Gala

The case for Ivy Rx

7.3/10

The record gives Ivy Rx no edge on this pair.

  • Names no compounding pharmacy
Visit Ivy Rx

Scores

Gala 8.5 · Ivy Rx 7.3 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Ivy Rx: questions

Neither Gala nor Ivy Rx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Gala, by $216 a year at standing rates. Gala: $179 a month, about $2,148 a year. Ivy Rx: $197 a month, about $2,364 a year.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Ivy Rx pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Ivy Rx 7.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks